Cargando…

Anthracycline-induced cardiomyopathy: Is there a new light at the end of the tunnel?

Detalles Bibliográficos
Autores principales:	Fradley, Michael G., Olshansky, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710614/ https://www.ncbi.nlm.nih.gov/pubmed/34988525 http://dx.doi.org/10.1016/j.hroo.2021.10.008

Ejemplares similares

Light at the end of the tunnel of Corti
por: Hanlon, Kilian, et al.
Publicado: (2023)

Craniofacial stem cell therapy: New light at the end of the tunnel
por: Balaji, S. M.
Publicado: (2014)

CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)

COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?
por: Bloem, Bastiaan R., et al.
Publicado: (2021)

Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel?
por: Hendaus, Mohamed A, et al.
Publicado: (2016)

Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?
por: Amygdalos, Iakovos, et al.
Publicado: (2023)

Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel
por: Lange, Christoph, et al.
Publicado: (2022)

Reference values for assessing the arms: are we seeing a light at the end of the tunnel?
por: Chiavegato, Luciana Dias
Publicado: (2018)

Light at the End of the Tunnel
por: Gupta, Piyush
Publicado: (2021)

Light at the end of the tunnel
por: Manohar, Balaji
Publicado: (2013)

The Light at the End of the Tunnel
por: Mando, Rufaat, et al.
Publicado: (2019)

Light at end of the tunnel
por: Hassard, J
Publicado: (1989)

Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
por: Riccio, Gennaro, et al.
Publicado: (2016)

Autonomic modulation: Getting it “just right”
por: Parker, William H., et al.
Publicado: (2023)

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
por: Distefano, Giuseppe
Publicado: (2009)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

The Second Surge of COVID-19: Better Prepared and a Brighter Light at the End of the Tunnel
por: Mont, M.A., et al.
Publicado: (2021)

2021: The Light at the End of the Tunnel?
por: Birkhoelzer, Sarah M., et al.
Publicado: (2021)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

There is light at the end of the tunnel, but we are still in the tunnel: universal preoperative SARS-CoV-2 testing and precautions remain vital in paediatrics
por: Adler, Adam C., et al.
Publicado: (2021)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel?
por: Montravers, Philippe, et al.
Publicado: (2020)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Endobronchial Optical Coherence Tomography for the Diagnosis of Fibrotic Interstitial Lung Disease: A Light at the End of the Tunnel?
por: Marinescu, Daniel-Costin, et al.
Publicado: (2021)

Antimicrobial Resistance: Is There a ‘Light’ at the End of the Tunnel?
por: Leanse, Leon G., et al.
Publicado: (2023)

New antidiabetic therapy and HFpEF: light at the end of tunnel?
por: Tadic, Marijana, et al.
Publicado: (2021)

The light at the end of the tunnel gets brighter
por: Anaïs Schaeffer
Publicado: (2014)

Coronavirus Vaccine: Light at the End of the Tunnel
por: Ella, Krishna M, et al.
Publicado: (2020)

The best time for extubation—daylight at the end of the tunnel?
por: Swanson, Jonathan R., et al.
Publicado: (2021)

Editorial: Inherited retinal dystrophies: a light at the end of the tunnel?
por: Perkins, Brian D., et al.
Publicado: (2023)

Working With a Psychopath: Is There Light at the End of the Tunnel?
por: Stewart, Jayme, et al.
Publicado: (2021)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Exercise-induced arrhythmogenic right ventricular cardiomyopathy: A clinical syndrome in motion
por: Wang, Norman C., et al.
Publicado: (2022)

Telemedicine shows us light at the end of the tunnel
por: Gupta, Harish, et al.
Publicado: (2021)

Finding relief at the end of the (Carpal) tunnel: Electrophysiological clues
por: Yip, Chun Wai, et al.
Publicado: (2013)

RNAi off-targeting: Light at the end of the tunnel
por: Brown, Kirk, et al.
Publicado: (2006)

Nitric oxide in fungi: is there NO light at the end of the tunnel?
por: Cánovas, David, et al.
Publicado: (2016)

Tunneled central venous catheters for dialysis – A necessary evil?
por: Kher, Vijay
Publicado: (2011)

Live, Genetically Attenuated, Cold-Chain-Free Cholera Vaccine—A Research and Development Journey: Light at the End of a Long Tunnel
por: RAVICHANDRAN, Manickam, et al.
Publicado: (2022)

Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
por: Desai, Lajja, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fvoiq8pvqp6mv3elpl6b9l81ur